Chairman Richard Morgan steps down from Motif Bio board
By Josh White
Date: Monday 18 Mar 2019
(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio announced on Monday that Richard Morgan had tendered his resignation as non-executive chairman, and was stepping down from the board of directors to focus on other business commitments, effective immediately.
The AIM-traded firm said Bruce Williams, a long-standing board member, had been appointed interim chairman.
Morgan had agreed to remain available to the company in the coming months on an as-needed basis, to ensure a smooth transition.
"On behalf of Motif Bio and the board of directors, I thank Richard for his mentorship, dedicated service and support over many years since the foundation of Motif Bio and wish him the best in his future endeavours," said Motif Bio chief executive officer Graham Lumsden.
"We are delighted that Bruce has agreed to step into the interim chairman role."
Lumsden said Williams was a "strong leader" who had held senior executive positions, particularly in strategic product planning and commercialisation, at a number of biopharmaceutical companies.
"I look forward to continuing to work with him as Motif Bio seeks to advance iclaprim towards approval.
"We have submitted a meeting request and package to the FDA and expect to work collaboratively with the agency over the coming weeks."
As at 1058 GMT, shares in Motif Bio were down 0.25% at 5.69p in choppy trading.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN